AZATHIOPRINE
- Product NDC
- 16571-835
- 11-digit product format
- 165710835
- Labeler code
- 16571
- Product ID
- 16571-835_99588075-8b4a-45ec-90ca-2a23fdd8262a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Azathioprine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Rising Pharma Holdings, Inc.
- Application
- ANDA075568
- Marketing category
- ANDA
- Marketing start
- 2024-06-06
- Substance
- AZATHIOPRINE
- Active strength
- 50 mg/1
- Pharmacologic classes
- Nucleic Acid Synthesis Inhibitors [MoA], Nucleosides [CS], Purine Antimetabolite [EPC], Purines [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- AZATHIOPRINE
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| AZATHIOPRINE | 50 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | MRK240IY2L |
| Rxcui | 197388 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 16571-835-01 | AZATHIOPRINE | 100 in 1 BOTTLE | TABLET | 100 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 16571-835 | AZATHIOPRINE TABLET [RISING PHARMA HOLDINGS, INC.] | 4 | Current NDC, 1 package rows | 20250206_2ffa2fce-895d-469e-8667-b078560aec5f.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 16571-835-01 | 16571083501 | 100 TABLET in 1 BOTTLE (16571-835-01) | 100 tablet | 2024-06-06 | No | No | Current |